Suzanne M Hanlon Net Worth & Insider Trades
Suzanne M Hanlon - Sec, Zynerba Pharmaceuticals, Inc
What is Suzanne M Hanlon's Net Worth?
The current estimated net worth of Zynerba Pharmaceuticals, Inc's Sec, Suzanne M Hanlon, is estimated to be about $49.07K . Suzanne M Hanlon owns about 43,693 units of Zynerba Pharmaceuticals, Inc common stock. In the last 6 years at Zynerba Pharmaceuticals, Inc, Suzanne M Hanlon has sold an estimated value of $31.59K worth.
What is Suzanne M Hanlon's Past Insider Trading?
Suzanne M Hanlon's largest purchase order was 3,000 units , worth over $53.76K on August 17, 2016. Suzanne M Hanlon's largest sale order was 3,000 units , worth over $31.59K on August 17, 2016. In total, Suzanne M Hanlon has made about 8 transactions over 6 years of their time at Zynerba Pharmaceuticals, Inc. Suzanne M Hanlon usually trades in January, with the busiest year in 2018. The most recent transaction was a purchase order of 3,800 units , worth over $22.05K on August 7, 2018.
Suzanne M Hanlon
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Suzanne M Hanlon's' Mailing Address?
- Mailing address is 80 W. Lancaster Avenue, Suite 300 Devon PA 19333 PA
Zynerba Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Armando Anido | 2020 | $585,265 | $263,369 | - | $580,674 | $53,441 | $1,482,749 |
| Armando Anido | 2019 | $568,218 | $334,112 | - | $413,149 | $54,092 | $1,369,571 |
| Terri B. Sebree | 2020 | $450,883 | $209,660 | - | $428,858 | $26,251 | $1,115,652 |
| Terri B. Sebree | 2019 | $437,750 | $252,144 | $13,140 | $309,861 | $25,985 | $1,038,880 |
| James E. | 2020 | $409,932 | $129,129 | - | $303,775 | $43,763 | $886,599 |
| James E. | 2019 | $390,411 | $158,347 | - | $227,487 | $47,862 | $824,107 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1621443/000110465921052876/tm2111207-2_def14a.htm
What are Zynerba Pharmaceuticals, Inc's Past Insider Trades?
Zynerba Pharmaceuticals, Inc's most recent insider trade came on February 17, 2023 by Albert P Parker who sold 3,173 units worth $1.72K . In the last 8 years, insiders at Zynerba Pharmaceuticals, Inc have sold an estimated value of $167.28K and bought an estimated value of $2.45M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Kenneth Moch, Director, Armando Anido, Chairman & Chief Exec. Officer, and James Fickenscher, Chief Financial Officer .
Zynerba Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||